Efficacy of decitabine combined HIA regimen in the treatment of patients with refractory/relapsed acute myeloid leukemia
ZHENG Zhuojun
ZHU Yuandong
XIE Xiaobao
JIANG Jingting
Keywords：RelapseRefractoryAcute myelogenous leukemiaDecitabineHomoharringtonineFludarabine
Publication Date：2016-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 889-892 )